A study indicated that CTR1 rs10981694 SNP carriers showed more susceptibility to cisplatin-induced ototoxicity in non-small cell lung cancer patients (p = 0.01) [143], as listed in Table 1. The gene discussed is SLC31A1; the disease is non-small cell lung carcinoma.